Loomis, Sayles & Company’s STAAR Surgical STAA Stock Holding History
Bought
Maintained
Sold
Other funds holding STAA
BC
AIM
PAI
JSP
GCM
Loomis, Sayles & Company's STAA Position: Q2 2023 in Review
Loomis, Sayles & Company sold out of STAAR Surgical (STAA) in Q2 2023, closing a stake of 335,738 shares — an estimated $21.5M sold.
Loomis, Sayles & Company first reported a position in STAA in Q4 2019 and held it in 14 quarters. The position peaked at $56.1M in Q2 2021. 245 funds tracked by Wall St. Rank hold STAA as of Q2 2023.
- Loomis, Sayles & Company reported no remaining STAAR Surgical position as of Q2 2023 after selling out during the quarter.
- Loomis, Sayles & Company sold 335,738 STAAR Surgical shares in Q2 2023, an estimated $21.5M.
- Loomis, Sayles & Company first reported a position in STAAR Surgical in Q4 2019 and held it in 14 quarters.
- Loomis, Sayles & Company's STAAR Surgical position peaked at $56.1M in Q2 2021.
- 245 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2023.
Based on Loomis, Sayles & Company's 13F filing for Q2 2023, filed 11 Aug 2023.